| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drosophila melanogaster | 49 | 2026 | 789 | 7.320 |
Why?
|
| Social Behavior | 11 | 2026 | 214 | 5.440 |
Why?
|
| Drosophila Proteins | 41 | 2026 | 718 | 5.400 |
Why?
|
| Receptors, Notch | 15 | 2022 | 197 | 4.050 |
Why?
|
| Pan troglodytes | 5 | 2025 | 70 | 3.970 |
Why?
|
| Behavior, Animal | 12 | 2026 | 480 | 3.760 |
Why?
|
| Pan paniscus | 4 | 2025 | 7 | 3.340 |
Why?
|
| Rare Diseases | 8 | 2025 | 210 | 2.390 |
Why?
|
| Drosophila | 30 | 2026 | 739 | 2.380 |
Why?
|
| Animals | 127 | 2026 | 33912 | 2.300 |
Why?
|
| Horses | 8 | 2026 | 94 | 1.870 |
Why?
|
| Aggression | 3 | 2025 | 218 | 1.530 |
Why?
|
| Oxytocin | 2 | 2024 | 68 | 1.490 |
Why?
|
| Mutation, Missense | 15 | 2025 | 919 | 1.460 |
Why?
|
| Signal Transduction | 19 | 2026 | 4686 | 1.370 |
Why?
|
| Neuroglia | 7 | 2025 | 224 | 1.360 |
Why?
|
| Neurodevelopmental Disorders | 11 | 2026 | 629 | 1.360 |
Why?
|
| Phenotype | 23 | 2026 | 4497 | 1.300 |
Why?
|
| Dopamine | 2 | 2026 | 246 | 1.250 |
Why?
|
| Adenosine Triphosphate | 5 | 2026 | 265 | 1.250 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2026 | 588 | 1.240 |
Why?
|
| Microcephaly | 5 | 2025 | 347 | 1.170 |
Why?
|
| Attention | 4 | 2025 | 194 | 1.140 |
Why?
|
| Vocalization, Animal | 2 | 2025 | 19 | 1.110 |
Why?
|
| Emotions | 3 | 2025 | 350 | 1.090 |
Why?
|
| Kidney Tubules, Proximal | 4 | 2024 | 74 | 1.080 |
Why?
|
| Pigmentation | 2 | 2026 | 37 | 1.070 |
Why?
|
| Elephants | 2 | 2025 | 52 | 1.070 |
Why?
|
| Sphingolipids | 2 | 2026 | 47 | 1.040 |
Why?
|
| Genomics | 8 | 2026 | 1621 | 1.040 |
Why?
|
| Leukoencephalopathies | 2 | 2025 | 63 | 1.010 |
Why?
|
| Functional Laterality | 2 | 2025 | 177 | 0.960 |
Why?
|
| Glycerophospholipids | 1 | 2026 | 13 | 0.950 |
Why?
|
| Humans | 121 | 2026 | 131163 | 0.950 |
Why?
|
| Cues | 3 | 2025 | 80 | 0.940 |
Why?
|
| Membrane Proteins | 9 | 2024 | 1590 | 0.940 |
Why?
|
| Animals, Wild | 2 | 2026 | 32 | 0.930 |
Why?
|
| Tertiary Lymphoid Structures | 2 | 2025 | 9 | 0.930 |
Why?
|
| Male | 69 | 2026 | 64957 | 0.910 |
Why?
|
| Zebrafish | 9 | 2025 | 418 | 0.910 |
Why?
|
| Adenosine Monophosphate | 1 | 2025 | 47 | 0.910 |
Why?
|
| Antiviral Agents | 4 | 2025 | 807 | 0.890 |
Why?
|
| Acoustics | 1 | 2025 | 20 | 0.890 |
Why?
|
| Tool Use Behavior | 1 | 2025 | 1 | 0.890 |
Why?
|
| Music | 1 | 2025 | 17 | 0.890 |
Why?
|
| Laminin | 1 | 2025 | 66 | 0.880 |
Why?
|
| Alanine | 1 | 2025 | 160 | 0.870 |
Why?
|
| Developmental Disabilities | 11 | 2026 | 781 | 0.870 |
Why?
|
| Urination | 1 | 2025 | 23 | 0.870 |
Why?
|
| Japan | 8 | 2026 | 161 | 0.860 |
Why?
|
| Intellectual Disability | 11 | 2025 | 1089 | 0.860 |
Why?
|
| Reward | 4 | 2014 | 140 | 0.840 |
Why?
|
| Primates | 4 | 2023 | 82 | 0.830 |
Why?
|
| Biological Evolution | 1 | 2025 | 222 | 0.820 |
Why?
|
| Female | 66 | 2026 | 70963 | 0.810 |
Why?
|
| Mutation | 20 | 2026 | 6099 | 0.810 |
Why?
|
| Cannibalism | 1 | 2023 | 1 | 0.800 |
Why?
|
| Immunocompromised Host | 1 | 2025 | 315 | 0.780 |
Why?
|
| Castleman Disease | 1 | 2023 | 13 | 0.770 |
Why?
|
| Caudate Nucleus | 2 | 2013 | 33 | 0.760 |
Why?
|
| Kidney | 8 | 2026 | 1282 | 0.760 |
Why?
|
| Neurogenesis | 2 | 2021 | 206 | 0.750 |
Why?
|
| Hepatorenal Syndrome | 1 | 2023 | 31 | 0.740 |
Why?
|
| Zika Virus | 1 | 2024 | 150 | 0.720 |
Why?
|
| Disease Models, Animal | 19 | 2026 | 4697 | 0.720 |
Why?
|
| Prosthesis-Related Infections | 1 | 2024 | 197 | 0.710 |
Why?
|
| Eye Movements | 4 | 2025 | 69 | 0.710 |
Why?
|
| Acute Kidney Injury | 4 | 2024 | 705 | 0.700 |
Why?
|
| Zika Virus Infection | 1 | 2024 | 173 | 0.700 |
Why?
|
| Group Processes | 1 | 2021 | 48 | 0.680 |
Why?
|
| Recurrence | 2 | 2024 | 1489 | 0.680 |
Why?
|
| Thrombocytopenia | 1 | 2023 | 223 | 0.660 |
Why?
|
| Ethylene Glycols | 1 | 2020 | 1 | 0.640 |
Why?
|
| Polymethacrylic Acids | 1 | 2020 | 4 | 0.640 |
Why?
|
| Genes, Insect | 5 | 2022 | 100 | 0.640 |
Why?
|
| Software | 3 | 2019 | 733 | 0.610 |
Why?
|
| Protein Subunits | 3 | 2018 | 157 | 0.610 |
Why?
|
| Genes | 2 | 2019 | 308 | 0.610 |
Why?
|
| Nervous System | 1 | 2020 | 114 | 0.610 |
Why?
|
| Cooperative Behavior | 1 | 2021 | 224 | 0.600 |
Why?
|
| Visual Perception | 4 | 2025 | 128 | 0.590 |
Why?
|
| Communicable Diseases | 1 | 2021 | 155 | 0.570 |
Why?
|
| Genome, Human | 4 | 2021 | 1321 | 0.550 |
Why?
|
| Photoreceptor Cells, Invertebrate | 5 | 2025 | 50 | 0.540 |
Why?
|
| Ultraviolet Rays | 1 | 2018 | 192 | 0.520 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2018 | 468 | 0.510 |
Why?
|
| Anti-Bacterial Agents | 3 | 2026 | 2596 | 0.490 |
Why?
|
| tau Proteins | 3 | 2025 | 257 | 0.470 |
Why?
|
| Photic Stimulation | 3 | 2013 | 227 | 0.470 |
Why?
|
| Bevacizumab | 3 | 2025 | 59 | 0.470 |
Why?
|
| Brain | 8 | 2025 | 3175 | 0.460 |
Why?
|
| Genetic Testing | 4 | 2019 | 1106 | 0.460 |
Why?
|
| Proteinuria | 3 | 2025 | 109 | 0.460 |
Why?
|
| Heart-Assist Devices | 1 | 2024 | 1020 | 0.450 |
Why?
|
| Mitochondria | 8 | 2024 | 785 | 0.450 |
Why?
|
| Genetics | 1 | 2015 | 24 | 0.450 |
Why?
|
| Saccades | 3 | 2021 | 20 | 0.440 |
Why?
|
| Alleles | 7 | 2026 | 1673 | 0.430 |
Why?
|
| Portugal | 3 | 2026 | 10 | 0.430 |
Why?
|
| Mice | 24 | 2026 | 18301 | 0.410 |
Why?
|
| Inheritance Patterns | 1 | 2014 | 127 | 0.410 |
Why?
|
| Frameshift Mutation | 2 | 2025 | 200 | 0.410 |
Why?
|
| Time | 1 | 2014 | 92 | 0.410 |
Why?
|
| Neurophysiology | 1 | 2014 | 22 | 0.410 |
Why?
|
| Kidney Neoplasms | 3 | 2025 | 421 | 0.410 |
Why?
|
| Neoplasms | 6 | 2025 | 3016 | 0.400 |
Why?
|
| Reperfusion Injury | 3 | 2024 | 107 | 0.400 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2013 | 5 | 0.400 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 680 | 0.400 |
Why?
|
| Myosins | 1 | 2013 | 41 | 0.390 |
Why?
|
| Nephritis, Interstitial | 2 | 2024 | 41 | 0.390 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 288 | 0.390 |
Why?
|
| Disease | 1 | 2014 | 121 | 0.390 |
Why?
|
| Temperature | 1 | 2014 | 291 | 0.390 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 134 | 0.390 |
Why?
|
| Water | 1 | 2014 | 186 | 0.380 |
Why?
|
| Neurons | 11 | 2025 | 1979 | 0.380 |
Why?
|
| Brain Injuries | 1 | 2018 | 710 | 0.380 |
Why?
|
| Autism Spectrum Disorder | 3 | 2023 | 450 | 0.380 |
Why?
|
| RNA Interference | 1 | 2014 | 491 | 0.380 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 110 | 0.370 |
Why?
|
| Fixation, Ocular | 1 | 2012 | 19 | 0.370 |
Why?
|
| Goals | 1 | 2013 | 126 | 0.370 |
Why?
|
| Aged | 19 | 2026 | 21025 | 0.360 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2024 | 67 | 0.360 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 174 | 0.360 |
Why?
|
| Germ Cells | 1 | 2013 | 201 | 0.360 |
Why?
|
| Genetic Variation | 5 | 2025 | 1559 | 0.360 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2025 | 223 | 0.350 |
Why?
|
| Middle Aged | 15 | 2026 | 28601 | 0.350 |
Why?
|
| Protein Transport | 4 | 2014 | 366 | 0.350 |
Why?
|
| Endocytosis | 3 | 2015 | 121 | 0.350 |
Why?
|
| Oocytes | 1 | 2013 | 283 | 0.340 |
Why?
|
| Adult | 20 | 2026 | 31282 | 0.340 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 325 | 0.340 |
Why?
|
| Genetic Association Studies | 2 | 2025 | 819 | 0.340 |
Why?
|
| Choice Behavior | 1 | 2012 | 148 | 0.330 |
Why?
|
| Models, Animal | 3 | 2025 | 450 | 0.330 |
Why?
|
| Visual Cortex | 1 | 2012 | 125 | 0.320 |
Why?
|
| Epilepsy, Generalized | 2 | 2022 | 63 | 0.320 |
Why?
|
| Transcription Factors | 7 | 2024 | 2406 | 0.320 |
Why?
|
| Epilepsy | 4 | 2022 | 876 | 0.320 |
Why?
|
| Mammals | 4 | 2024 | 253 | 0.320 |
Why?
|
| Mitochondrial Dynamics | 2 | 2024 | 56 | 0.310 |
Why?
|
| Autistic Disorder | 3 | 2023 | 398 | 0.310 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2026 | 101 | 0.310 |
Why?
|
| Exome | 5 | 2022 | 1061 | 0.300 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2024 | 950 | 0.300 |
Why?
|
| Nervous System Malformations | 2 | 2022 | 135 | 0.300 |
Why?
|
| Brain Diseases | 2 | 2023 | 299 | 0.290 |
Why?
|
| Epidermal Growth Factor | 3 | 2022 | 115 | 0.290 |
Why?
|
| Databases, Factual | 2 | 2025 | 1240 | 0.290 |
Why?
|
| Kidney Diseases | 2 | 2023 | 477 | 0.280 |
Why?
|
| X Chromosome | 5 | 2020 | 327 | 0.280 |
Why?
|
| Animals, Genetically Modified | 5 | 2023 | 291 | 0.280 |
Why?
|
| Macaca mulatta | 5 | 2024 | 504 | 0.270 |
Why?
|
| Nerve Degeneration | 2 | 2020 | 128 | 0.270 |
Why?
|
| Rats | 8 | 2024 | 3370 | 0.270 |
Why?
|
| Nervous System Diseases | 2 | 2023 | 395 | 0.260 |
Why?
|
| Amino Acid Sequence | 6 | 2021 | 2395 | 0.260 |
Why?
|
| Podocytes | 2 | 2024 | 75 | 0.260 |
Why?
|
| Retinal Degeneration | 3 | 2025 | 84 | 0.260 |
Why?
|
| Loss of Function Mutation | 4 | 2024 | 177 | 0.260 |
Why?
|
| Basal Ganglia | 2 | 2021 | 60 | 0.250 |
Why?
|
| Craniofacial Abnormalities | 4 | 2023 | 251 | 0.250 |
Why?
|
| Glycolysis | 2 | 2026 | 174 | 0.250 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2024 | 853 | 0.250 |
Why?
|
| Melanins | 1 | 2026 | 18 | 0.250 |
Why?
|
| Dopa Decarboxylase | 1 | 2026 | 9 | 0.250 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2026 | 25 | 0.250 |
Why?
|
| Antineoplastic Agents, Immunological | 2 | 2025 | 127 | 0.240 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2026 | 46 | 0.240 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2026 | 289 | 0.240 |
Why?
|
| Axin Protein | 1 | 2026 | 32 | 0.240 |
Why?
|
| Vision, Ocular | 2 | 2025 | 117 | 0.240 |
Why?
|
| Dopaminergic Neurons | 1 | 2026 | 52 | 0.240 |
Why?
|
| Campylobacter fetus | 1 | 2026 | 4 | 0.240 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2026 | 46 | 0.240 |
Why?
|
| Cell Movement | 1 | 2010 | 876 | 0.240 |
Why?
|
| Vesicular Transport Proteins | 3 | 2017 | 138 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 3436 | 0.240 |
Why?
|
| Nephrons | 1 | 2026 | 17 | 0.240 |
Why?
|
| Pyridazines | 2 | 2024 | 49 | 0.240 |
Why?
|
| Campylobacter Infections | 1 | 2026 | 33 | 0.240 |
Why?
|
| Corynebacterium Infections | 1 | 2025 | 5 | 0.230 |
Why?
|
| Alzheimer Disease | 3 | 2025 | 878 | 0.230 |
Why?
|
| Neurodegenerative Diseases | 4 | 2017 | 280 | 0.230 |
Why?
|
| Daptomycin | 1 | 2025 | 17 | 0.230 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2025 | 16 | 0.230 |
Why?
|
| Corynebacterium | 1 | 2025 | 13 | 0.230 |
Why?
|
| Learning | 3 | 2021 | 356 | 0.230 |
Why?
|
| Retreatment | 1 | 2025 | 85 | 0.230 |
Why?
|
| Orientation | 1 | 2025 | 35 | 0.230 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2025 | 5 | 0.230 |
Why?
|
| Organogenesis | 1 | 2026 | 75 | 0.230 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2023 | 167 | 0.230 |
Why?
|
| Calcium Channels | 2 | 2017 | 143 | 0.230 |
Why?
|
| Phospholipase C gamma | 1 | 2025 | 27 | 0.230 |
Why?
|
| Happiness | 1 | 2025 | 11 | 0.230 |
Why?
|
| Glomerulonephritis | 1 | 2026 | 74 | 0.230 |
Why?
|
| Child | 21 | 2026 | 26341 | 0.230 |
Why?
|
| Amino Acid Substitution | 2 | 2020 | 405 | 0.220 |
Why?
|
| Rhodopsin | 3 | 2015 | 60 | 0.220 |
Why?
|
| Somatosensory Cortex | 2 | 2024 | 54 | 0.220 |
Why?
|
| Histones | 3 | 2023 | 541 | 0.220 |
Why?
|
| Facial Expression | 1 | 2025 | 22 | 0.220 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2025 | 39 | 0.220 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2025 | 19 | 0.220 |
Why?
|
| Lymphoid Tissue | 1 | 2025 | 47 | 0.220 |
Why?
|
| Social Learning | 1 | 2025 | 9 | 0.220 |
Why?
|
| Arteritis | 1 | 2024 | 7 | 0.220 |
Why?
|
| Databases, Genetic | 4 | 2022 | 504 | 0.220 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2024 | 14 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3763 | 0.220 |
Why?
|
| Fibronectins | 1 | 2025 | 99 | 0.220 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2024 | 18 | 0.220 |
Why?
|
| Gene Regulatory Networks | 3 | 2023 | 373 | 0.210 |
Why?
|
| Prednisolone | 1 | 2024 | 74 | 0.210 |
Why?
|
| rab GTP-Binding Proteins | 3 | 2014 | 52 | 0.210 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2025 | 81 | 0.210 |
Why?
|
| Renal Artery Obstruction | 1 | 2024 | 40 | 0.210 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2024 | 8 | 0.210 |
Why?
|
| Plasma Cells | 1 | 2024 | 55 | 0.210 |
Why?
|
| Angioplasty | 1 | 2024 | 63 | 0.210 |
Why?
|
| Endocarditis, Bacterial | 1 | 2025 | 128 | 0.210 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2024 | 35 | 0.210 |
Why?
|
| Mitochondrial Proteins | 3 | 2015 | 283 | 0.210 |
Why?
|
| Blood-Brain Barrier | 1 | 2025 | 153 | 0.210 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2025 | 160 | 0.210 |
Why?
|
| Proteins | 2 | 2019 | 1006 | 0.210 |
Why?
|
| Fibrinogen | 1 | 2025 | 170 | 0.210 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2024 | 40 | 0.210 |
Why?
|
| Cats | 1 | 2024 | 117 | 0.210 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2024 | 61 | 0.200 |
Why?
|
| Species Specificity | 1 | 2024 | 470 | 0.200 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 429 | 0.200 |
Why?
|
| Language Development Disorders | 2 | 2022 | 177 | 0.200 |
Why?
|
| Models, Biological | 2 | 2025 | 1371 | 0.200 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2023 | 22 | 0.200 |
Why?
|
| Fear | 1 | 2025 | 190 | 0.200 |
Why?
|
| Cercopithecidae | 1 | 2023 | 8 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 1 | 2025 | 229 | 0.200 |
Why?
|
| Steroids | 1 | 2024 | 170 | 0.200 |
Why?
|
| Oxidative Phosphorylation | 1 | 2024 | 142 | 0.200 |
Why?
|
| Deafness | 1 | 2024 | 77 | 0.200 |
Why?
|
| Drug Hypersensitivity Syndrome | 1 | 2023 | 8 | 0.200 |
Why?
|
| Dysbiosis | 1 | 2024 | 145 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 4 | 2026 | 1075 | 0.200 |
Why?
|
| Radiation Injuries | 1 | 2024 | 141 | 0.200 |
Why?
|
| Fibroblasts | 2 | 2025 | 849 | 0.200 |
Why?
|
| Hypertensive Retinopathy | 1 | 2023 | 1 | 0.200 |
Why?
|
| Autoimmune Diseases | 1 | 2026 | 262 | 0.190 |
Why?
|
| Bacteriophages | 1 | 2024 | 101 | 0.190 |
Why?
|
| Cadaver | 1 | 2023 | 114 | 0.190 |
Why?
|
| Neurosyphilis | 1 | 2023 | 15 | 0.190 |
Why?
|
| Lymphocytes | 1 | 2024 | 344 | 0.190 |
Why?
|
| Dogs | 1 | 2024 | 613 | 0.190 |
Why?
|
| Nasal Cavity | 1 | 2023 | 56 | 0.190 |
Why?
|
| BK Virus | 1 | 2023 | 58 | 0.190 |
Why?
|
| RNA-Binding Proteins | 2 | 2025 | 533 | 0.190 |
Why?
|
| Uveitis | 1 | 2023 | 36 | 0.190 |
Why?
|
| Dermatologic Agents | 1 | 2023 | 28 | 0.190 |
Why?
|
| Immune Evasion | 1 | 2022 | 38 | 0.190 |
Why?
|
| Voice | 1 | 2022 | 13 | 0.180 |
Why?
|
| Stillbirth | 1 | 2023 | 95 | 0.180 |
Why?
|
| Polyomavirus Infections | 1 | 2023 | 87 | 0.180 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2025 | 401 | 0.180 |
Why?
|
| Tumor Virus Infections | 1 | 2023 | 131 | 0.180 |
Why?
|
| Cdh1 Proteins | 1 | 2022 | 9 | 0.180 |
Why?
|
| Cisplatin | 1 | 2024 | 274 | 0.180 |
Why?
|
| Antibodies, Viral | 6 | 2023 | 1176 | 0.180 |
Why?
|
| Syphilis | 1 | 2023 | 96 | 0.180 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2022 | 5 | 0.180 |
Why?
|
| Lipid Droplets | 3 | 2024 | 51 | 0.180 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2023 | 103 | 0.180 |
Why?
|
| Interpersonal Relations | 1 | 2024 | 223 | 0.180 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 2 | 2020 | 59 | 0.180 |
Why?
|
| Receptors, Glycine | 1 | 2022 | 16 | 0.180 |
Why?
|
| Eosinophilia | 1 | 2023 | 112 | 0.180 |
Why?
|
| Edema | 1 | 2023 | 130 | 0.180 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2023 | 160 | 0.180 |
Why?
|
| Antibodies, Neutralizing | 5 | 2023 | 525 | 0.180 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2022 | 27 | 0.180 |
Why?
|
| Retrospective Studies | 6 | 2026 | 17753 | 0.180 |
Why?
|
| Mutagenesis, Insertional | 2 | 2019 | 150 | 0.170 |
Why?
|
| Kidney Pelvis | 1 | 2021 | 33 | 0.170 |
Why?
|
| Viral Envelope Proteins | 1 | 2022 | 155 | 0.170 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 251 | 0.170 |
Why?
|
| beta Karyopherins | 1 | 2021 | 15 | 0.170 |
Why?
|
| Peptide Fragments | 1 | 2025 | 687 | 0.170 |
Why?
|
| Growth Differentiation Factors | 1 | 2021 | 11 | 0.170 |
Why?
|
| ran GTP-Binding Protein | 1 | 2021 | 25 | 0.170 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 123 | 0.170 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2021 | 31 | 0.170 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 133 | 0.170 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2021 | 27 | 0.170 |
Why?
|
| Karyopherins | 1 | 2021 | 35 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2023 | 218 | 0.170 |
Why?
|
| Aircraft | 1 | 2021 | 18 | 0.170 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 326 | 0.170 |
Why?
|
| B7 Antigens | 1 | 2021 | 17 | 0.170 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2022 | 196 | 0.160 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 483 | 0.160 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2023 | 241 | 0.160 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2020 | 41 | 0.160 |
Why?
|
| Gene Expression Regulation | 6 | 2022 | 2323 | 0.160 |
Why?
|
| Bacteria | 1 | 2024 | 521 | 0.160 |
Why?
|
| Glucose | 1 | 2025 | 853 | 0.160 |
Why?
|
| Organ Size | 2 | 2018 | 407 | 0.160 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 127 | 0.160 |
Why?
|
| Corpus Striatum | 1 | 2021 | 96 | 0.160 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 279 | 0.160 |
Why?
|
| Research Personnel | 1 | 2022 | 139 | 0.160 |
Why?
|
| Risk Factors | 2 | 2025 | 11074 | 0.160 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 3 | 2026 | 40 | 0.160 |
Why?
|
| Liver Transplantation | 2 | 2026 | 1147 | 0.160 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 3464 | 0.160 |
Why?
|
| Genes, Neoplasm | 1 | 2020 | 80 | 0.160 |
Why?
|
| Photography | 1 | 2021 | 79 | 0.160 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2020 | 10 | 0.160 |
Why?
|
| Electric Stimulation | 3 | 2024 | 234 | 0.160 |
Why?
|
| Inflammation | 2 | 2025 | 1489 | 0.160 |
Why?
|
| Ligands | 2 | 2012 | 481 | 0.150 |
Why?
|
| Pedigree | 4 | 2025 | 1677 | 0.150 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 82 | 0.150 |
Why?
|
| Delivery of Health Care | 1 | 2026 | 689 | 0.150 |
Why?
|
| Zellweger Syndrome | 1 | 2020 | 16 | 0.150 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2020 | 252 | 0.150 |
Why?
|
| Peroxisomes | 1 | 2020 | 42 | 0.150 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 571 | 0.150 |
Why?
|
| WD40 Repeats | 1 | 2019 | 8 | 0.150 |
Why?
|
| Virulence Factors | 1 | 2021 | 180 | 0.150 |
Why?
|
| Congenital Abnormalities | 1 | 2023 | 330 | 0.150 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 400 | 0.150 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2019 | 16 | 0.150 |
Why?
|
| Rats, Wistar | 2 | 2018 | 299 | 0.150 |
Why?
|
| Interneurons | 1 | 2021 | 146 | 0.150 |
Why?
|
| Homologous Recombination | 1 | 2019 | 97 | 0.150 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 437 | 0.150 |
Why?
|
| Prognosis | 4 | 2025 | 4886 | 0.150 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 118 | 0.150 |
Why?
|
| Heterozygote | 3 | 2026 | 737 | 0.150 |
Why?
|
| Axons | 2 | 2020 | 386 | 0.150 |
Why?
|
| Coloboma | 1 | 2019 | 41 | 0.150 |
Why?
|
| Embryo, Nonmammalian | 1 | 2019 | 141 | 0.150 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2020 | 209 | 0.140 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2019 | 17 | 0.140 |
Why?
|
| Social Perception | 1 | 2019 | 52 | 0.140 |
Why?
|
| Transcriptome | 2 | 2025 | 1103 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 254 | 0.140 |
Why?
|
| Aging | 2 | 2025 | 1242 | 0.140 |
Why?
|
| Central Nervous System | 2 | 2017 | 269 | 0.140 |
Why?
|
| Autophagy | 3 | 2016 | 417 | 0.140 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2019 | 78 | 0.140 |
Why?
|
| Protein Domains | 1 | 2020 | 252 | 0.140 |
Why?
|
| Bloodless Medical and Surgical Procedures | 1 | 2018 | 3 | 0.140 |
Why?
|
| Calcium Channels, N-Type | 2 | 2017 | 47 | 0.140 |
Why?
|
| Vaccines | 1 | 2023 | 388 | 0.140 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 478 | 0.140 |
Why?
|
| Tretinoin | 1 | 2019 | 95 | 0.140 |
Why?
|
| Food | 1 | 2019 | 121 | 0.140 |
Why?
|
| Myofibroblasts | 1 | 2019 | 64 | 0.140 |
Why?
|
| Child, Preschool | 10 | 2025 | 15110 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 619 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 552 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2025 | 1717 | 0.140 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2018 | 22 | 0.140 |
Why?
|
| Virus Replication | 1 | 2021 | 608 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2021 | 406 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 3 | 2019 | 1692 | 0.140 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2017 | 11 | 0.130 |
Why?
|
| Embryonic Development | 1 | 2019 | 200 | 0.130 |
Why?
|
| Cell Count | 1 | 2018 | 212 | 0.130 |
Why?
|
| Myosin Type V | 1 | 2017 | 9 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 484 | 0.130 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 34 | 0.130 |
Why?
|
| Cerebellum | 2 | 2019 | 441 | 0.130 |
Why?
|
| DiGeorge Syndrome | 1 | 2018 | 83 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 507 | 0.130 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 74 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2022 | 889 | 0.130 |
Why?
|
| Motor Neurons | 2 | 2026 | 131 | 0.130 |
Why?
|
| Gene Library | 1 | 2018 | 212 | 0.130 |
Why?
|
| Syndrome | 4 | 2024 | 1155 | 0.130 |
Why?
|
| Liver | 1 | 2025 | 1796 | 0.130 |
Why?
|
| T-Box Domain Proteins | 1 | 2018 | 123 | 0.130 |
Why?
|
| Nephrectomy | 1 | 2018 | 158 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 6797 | 0.130 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2020 | 280 | 0.130 |
Why?
|
| Cell Differentiation | 4 | 2017 | 1928 | 0.130 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2016 | 13 | 0.130 |
Why?
|
| Stem Cell Niche | 1 | 2017 | 55 | 0.130 |
Why?
|
| Cerebellar Ataxia | 1 | 2017 | 61 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2024 | 948 | 0.120 |
Why?
|
| Electron Transport Complex I | 2 | 2015 | 29 | 0.120 |
Why?
|
| Tropomyosin | 1 | 2016 | 26 | 0.120 |
Why?
|
| Brain Mapping | 2 | 2024 | 384 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2024 | 842 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 146 | 0.120 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2016 | 14 | 0.120 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2016 | 18 | 0.120 |
Why?
|
| Metalloendopeptidases | 1 | 2016 | 101 | 0.120 |
Why?
|
| Iron-Binding Proteins | 1 | 2016 | 25 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 3 | 2024 | 208 | 0.120 |
Why?
|
| Friedreich Ataxia | 1 | 2016 | 29 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 143 | 0.120 |
Why?
|
| Internet | 1 | 2019 | 420 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2022 | 712 | 0.120 |
Why?
|
| Ovarian Follicle | 1 | 2017 | 127 | 0.120 |
Why?
|
| Lysosomes | 2 | 2015 | 268 | 0.120 |
Why?
|
| Spike Glycoprotein, Coronavirus | 3 | 2022 | 215 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 195 | 0.110 |
Why?
|
| Haploinsufficiency | 3 | 2024 | 266 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2026 | 2326 | 0.110 |
Why?
|
| Infant | 8 | 2025 | 13352 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 2022 | 993 | 0.110 |
Why?
|
| Retina | 1 | 2018 | 425 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 521 | 0.110 |
Why?
|
| Synapses | 2 | 2018 | 425 | 0.110 |
Why?
|
| Genetic Techniques | 1 | 2015 | 95 | 0.110 |
Why?
|
| Phagosomes | 1 | 2015 | 38 | 0.110 |
Why?
|
| Visual Pathways | 2 | 2012 | 84 | 0.110 |
Why?
|
| Testis | 1 | 2017 | 389 | 0.110 |
Why?
|
| Operative Blood Salvage | 1 | 2014 | 1 | 0.110 |
Why?
|
| Ecdysone | 1 | 2014 | 4 | 0.110 |
Why?
|
| Obstetric Surgical Procedures | 1 | 2014 | 6 | 0.110 |
Why?
|
| Registries | 1 | 2022 | 1634 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2304 | 0.110 |
Why?
|
| Endosomes | 1 | 2015 | 70 | 0.110 |
Why?
|
| Kidney Glomerulus | 2 | 2025 | 81 | 0.110 |
Why?
|
| Eye | 1 | 2016 | 215 | 0.110 |
Why?
|
| Pregnancy | 3 | 2023 | 7512 | 0.110 |
Why?
|
| Genetic Research | 1 | 2015 | 58 | 0.110 |
Why?
|
| Electrical Equipment and Supplies | 1 | 2014 | 3 | 0.110 |
Why?
|
| Ataxia | 3 | 2022 | 160 | 0.100 |
Why?
|
| Young Adult | 7 | 2025 | 10103 | 0.100 |
Why?
|
| Electric Conductivity | 1 | 2014 | 79 | 0.100 |
Why?
|
| Computational Biology | 1 | 2019 | 862 | 0.100 |
Why?
|
| rab1 GTP-Binding Proteins | 1 | 2014 | 3 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2016 | 239 | 0.100 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2014 | 4 | 0.100 |
Why?
|
| Pigments, Biological | 1 | 2014 | 7 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1272 | 0.100 |
Why?
|
| Peripheral Nervous System | 1 | 2014 | 44 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2015 | 365 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2014 | 66 | 0.100 |
Why?
|
| Insect Proteins | 1 | 2014 | 95 | 0.100 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 534 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 354 | 0.100 |
Why?
|
| Mutagenesis | 1 | 2014 | 324 | 0.100 |
Why?
|
| Retinal Diseases | 1 | 2015 | 142 | 0.100 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 168 | 0.100 |
Why?
|
| Cytokinesis | 1 | 2013 | 23 | 0.100 |
Why?
|
| Actin Cytoskeleton | 1 | 2013 | 48 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1336 | 0.100 |
Why?
|
| Oogenesis | 1 | 2013 | 50 | 0.100 |
Why?
|
| Iron | 1 | 2016 | 304 | 0.100 |
Why?
|
| Erythrocyte Transfusion | 1 | 2014 | 146 | 0.100 |
Why?
|
| Hearing | 2 | 2024 | 58 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 4738 | 0.100 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 43 | 0.100 |
Why?
|
| Receptor, Notch2 | 1 | 2012 | 12 | 0.100 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2012 | 35 | 0.090 |
Why?
|
| Wnt Signaling Pathway | 2 | 2026 | 223 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2018 | 541 | 0.090 |
Why?
|
| Tandem Repeat Sequences | 1 | 2012 | 37 | 0.090 |
Why?
|
| Substantia Nigra | 1 | 2012 | 35 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 1826 | 0.090 |
Why?
|
| Jagged-1 Protein | 1 | 2012 | 51 | 0.090 |
Why?
|
| Gain of Function Mutation | 2 | 2023 | 115 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 1419 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1586 | 0.090 |
Why?
|
| Random Allocation | 1 | 2013 | 409 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2023 | 2550 | 0.090 |
Why?
|
| Equipment Design | 1 | 2014 | 512 | 0.090 |
Why?
|
| Valine | 1 | 2012 | 110 | 0.090 |
Why?
|
| Algorithms | 1 | 2019 | 1680 | 0.090 |
Why?
|
| Methionine | 1 | 2012 | 95 | 0.090 |
Why?
|
| Asymmetric Cell Division | 1 | 2012 | 7 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 1046 | 0.090 |
Why?
|
| Neuromuscular Junction | 3 | 2020 | 87 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 359 | 0.090 |
Why?
|
| Exocytosis | 1 | 2012 | 65 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2019 | 910 | 0.090 |
Why?
|
| Whole Genome Sequencing | 2 | 2025 | 362 | 0.090 |
Why?
|
| Cricetinae | 2 | 2022 | 362 | 0.090 |
Why?
|
| Visual Fields | 1 | 2012 | 133 | 0.080 |
Why?
|
| Memory | 1 | 2014 | 314 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 327 | 0.080 |
Why?
|
| Motivation | 1 | 2013 | 328 | 0.080 |
Why?
|
| Photoreceptor Cells | 2 | 2025 | 89 | 0.080 |
Why?
|
| Actins | 2 | 2023 | 321 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2024 | 786 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2014 | 749 | 0.080 |
Why?
|
| Motor Activity | 1 | 2014 | 489 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 775 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2012 | 928 | 0.080 |
Why?
|
| Neurons, Efferent | 1 | 2010 | 1 | 0.080 |
Why?
|
| Trigeminal Nuclei | 1 | 2010 | 1 | 0.080 |
Why?
|
| Time Factors | 1 | 2020 | 6196 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2019 | 2465 | 0.080 |
Why?
|
| ROC Curve | 1 | 2012 | 613 | 0.080 |
Why?
|
| Neurons, Afferent | 1 | 2010 | 39 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 713 | 0.080 |
Why?
|
| Lysine | 2 | 2023 | 167 | 0.080 |
Why?
|
| Action Potentials | 1 | 2012 | 476 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 644 | 0.070 |
Why?
|
| Thalamus | 1 | 2010 | 93 | 0.070 |
Why?
|
| Sense Organs | 1 | 2009 | 16 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2012 | 2885 | 0.070 |
Why?
|
| Infant, Newborn | 5 | 2021 | 8635 | 0.070 |
Why?
|
| Biopsy | 2 | 2026 | 1239 | 0.070 |
Why?
|
| Cognition | 1 | 2014 | 829 | 0.070 |
Why?
|
| Dental Enamel Proteins | 1 | 2007 | 3 | 0.070 |
Why?
|
| Receptor, trkB | 1 | 2007 | 22 | 0.070 |
Why?
|
| Protein Binding | 3 | 2020 | 1652 | 0.070 |
Why?
|
| Adolescent | 5 | 2025 | 20987 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 65 | 0.070 |
Why?
|
| Muscle Hypotonia | 2 | 2020 | 194 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2017 | 129 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2009 | 349 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 825 | 0.060 |
Why?
|
| Vaccination | 2 | 2023 | 1060 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2026 | 1882 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 445 | 0.060 |
Why?
|
| Age of Onset | 2 | 2020 | 592 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 664 | 0.060 |
Why?
|
| Renal Dialysis | 2 | 2025 | 951 | 0.060 |
Why?
|
| Tankyrases | 1 | 2026 | 16 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2024 | 3819 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2018 | 136 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 1211 | 0.060 |
Why?
|
| Ectodermal Dysplasia | 1 | 2026 | 62 | 0.060 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2025 | 6 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2024 | 1105 | 0.060 |
Why?
|
| Grooming | 1 | 2024 | 9 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2006 | 255 | 0.060 |
Why?
|
| Lysogeny | 1 | 2024 | 11 | 0.050 |
Why?
|
| Cell Line | 3 | 2019 | 2552 | 0.050 |
Why?
|
| Oligomycins | 1 | 2024 | 3 | 0.050 |
Why?
|
| Phloretin | 1 | 2024 | 3 | 0.050 |
Why?
|
| Cimetidine | 1 | 2024 | 16 | 0.050 |
Why?
|
| Kidney Tubules, Distal | 1 | 2024 | 17 | 0.050 |
Why?
|
| Lung | 2 | 2023 | 1535 | 0.050 |
Why?
|
| Abnormalities, Multiple | 2 | 2023 | 963 | 0.050 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2024 | 4 | 0.050 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2024 | 3 | 0.050 |
Why?
|
| Macaca | 1 | 2024 | 60 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2024 | 13 | 0.050 |
Why?
|
| Social Networking | 1 | 2024 | 14 | 0.050 |
Why?
|
| Proprotein Convertases | 1 | 2024 | 25 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2024 | 69 | 0.050 |
Why?
|
| Facial Recognition | 1 | 2024 | 6 | 0.050 |
Why?
|
| Tauopathies | 1 | 2025 | 72 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2024 | 84 | 0.050 |
Why?
|
| Microfilament Proteins | 2 | 2019 | 269 | 0.050 |
Why?
|
| Muscle Proteins | 2 | 2019 | 401 | 0.050 |
Why?
|
| Zebrafish Proteins | 2 | 2020 | 133 | 0.050 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2024 | 49 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2024 | 140 | 0.050 |
Why?
|
| Face | 1 | 2025 | 192 | 0.050 |
Why?
|
| Electroretinography | 2 | 2015 | 96 | 0.050 |
Why?
|
| Abdomen | 1 | 2024 | 126 | 0.050 |
Why?
|
| Vertebrates | 1 | 2024 | 36 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2025 | 190 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2024 | 83 | 0.050 |
Why?
|
| Congenital Hypothyroidism | 1 | 2023 | 7 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2026 | 194 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2023 | 121 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2025 | 5063 | 0.050 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2023 | 33 | 0.050 |
Why?
|
| Pacemaker, Artificial | 1 | 2026 | 193 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2024 | 117 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2006 | 273 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2025 | 357 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2024 | 197 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2024 | 448 | 0.050 |
Why?
|
| Hypertension, Renal | 1 | 2023 | 30 | 0.050 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2023 | 69 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 199 | 0.050 |
Why?
|
| Nephritis | 1 | 2023 | 17 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 2014 | 258 | 0.050 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 40 | 0.050 |
Why?
|
| Connectome | 1 | 2024 | 111 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2006 | 892 | 0.050 |
Why?
|
| Imatinib Mesylate | 1 | 2023 | 47 | 0.050 |
Why?
|
| Sclerosis | 1 | 2023 | 31 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2023 | 95 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2023 | 78 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2022 | 24 | 0.050 |
Why?
|
| Light | 2 | 2014 | 166 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2024 | 235 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 801 | 0.050 |
Why?
|
| Synaptic Transmission | 2 | 2015 | 299 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2023 | 158 | 0.050 |
Why?
|
| Hypothermia, Induced | 1 | 2024 | 172 | 0.050 |
Why?
|
| Nose | 1 | 2023 | 115 | 0.050 |
Why?
|
| Body Temperature | 1 | 2023 | 126 | 0.050 |
Why?
|
| Sound | 1 | 2022 | 19 | 0.050 |
Why?
|
| Neuraminidase | 1 | 2022 | 40 | 0.050 |
Why?
|
| Hand Deformities, Congenital | 1 | 2023 | 96 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 201 | 0.050 |
Why?
|
| Hydroxylamines | 1 | 2022 | 7 | 0.050 |
Why?
|
| Nasal Mucosa | 1 | 2023 | 88 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2023 | 87 | 0.050 |
Why?
|
| Cytidine | 1 | 2022 | 13 | 0.050 |
Why?
|
| Blindness | 1 | 2023 | 70 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2025 | 859 | 0.050 |
Why?
|
| Indazoles | 1 | 2022 | 35 | 0.050 |
Why?
|
| Precision Medicine | 1 | 2026 | 388 | 0.050 |
Why?
|
| Lactams | 1 | 2022 | 23 | 0.050 |
Why?
|
| Triazines | 1 | 2022 | 35 | 0.050 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2022 | 4 | 0.050 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2022 | 59 | 0.050 |
Why?
|
| Creatinine | 1 | 2024 | 398 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2025 | 509 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2022 | 120 | 0.040 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2022 | 131 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2022 | 226 | 0.040 |
Why?
|
| Heart Rate | 1 | 2025 | 577 | 0.040 |
Why?
|
| Proline | 1 | 2022 | 80 | 0.040 |
Why?
|
| Ribonuclease III | 1 | 2022 | 100 | 0.040 |
Why?
|
| Nerve Net | 1 | 2024 | 254 | 0.040 |
Why?
|
| Wnt1 Protein | 1 | 2022 | 71 | 0.040 |
Why?
|
| Stem Cells | 1 | 2006 | 702 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 152 | 0.040 |
Why?
|
| Polycomb-Group Proteins | 1 | 2021 | 24 | 0.040 |
Why?
|
| Nitriles | 1 | 2022 | 163 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2022 | 414 | 0.040 |
Why?
|
| Imidazoles | 1 | 2023 | 219 | 0.040 |
Why?
|
| Mesocricetus | 1 | 2021 | 65 | 0.040 |
Why?
|
| Triazoles | 1 | 2022 | 141 | 0.040 |
Why?
|
| Ischemia | 1 | 2024 | 359 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2024 | 269 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 566 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2026 | 1246 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2022 | 270 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2023 | 978 | 0.040 |
Why?
|
| Genes, Homeobox | 1 | 2021 | 61 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2024 | 523 | 0.040 |
Why?
|
| Adamantane | 1 | 2021 | 9 | 0.040 |
Why?
|
| Leucine | 1 | 2022 | 259 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2022 | 148 | 0.040 |
Why?
|
| Feces | 1 | 2024 | 721 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2025 | 381 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 1939 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 101 | 0.040 |
Why?
|
| Seasons | 1 | 2022 | 335 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2020 | 50 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2026 | 804 | 0.040 |
Why?
|
| Consensus | 1 | 2023 | 512 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 587 | 0.040 |
Why?
|
| Reflex, Abnormal | 1 | 2020 | 13 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 623 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2020 | 12 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2022 | 405 | 0.040 |
Why?
|
| Neural Pathways | 2 | 2013 | 270 | 0.040 |
Why?
|
| Spine | 1 | 2021 | 153 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2020 | 242 | 0.040 |
Why?
|
| Environment | 1 | 2021 | 149 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2021 | 582 | 0.040 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 124 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2022 | 323 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2019 | 905 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2017 | 1571 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2021 | 435 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 1833 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 57 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 335 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2022 | 556 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2023 | 446 | 0.040 |
Why?
|
| DNA, Single-Stranded | 1 | 2019 | 69 | 0.040 |
Why?
|
| Problem Solving | 1 | 2019 | 61 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 499 | 0.040 |
Why?
|
| Diphtheria Toxin | 1 | 2019 | 15 | 0.040 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2019 | 18 | 0.040 |
Why?
|
| Retinal Dehydrogenase | 1 | 2019 | 18 | 0.040 |
Why?
|
| Lipocalin-2 | 1 | 2019 | 29 | 0.040 |
Why?
|
| Benzoates | 1 | 2019 | 24 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2019 | 77 | 0.040 |
Why?
|
| Stilbenes | 1 | 2019 | 33 | 0.040 |
Why?
|
| Microdissection | 1 | 2018 | 13 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 645 | 0.040 |
Why?
|
| Stents | 1 | 2024 | 799 | 0.040 |
Why?
|
| Incidence | 1 | 2026 | 3360 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 350 | 0.030 |
Why?
|
| Dystonia | 1 | 2020 | 165 | 0.030 |
Why?
|
| Ligation | 1 | 2018 | 134 | 0.030 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2018 | 51 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 597 | 0.030 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2017 | 9 | 0.030 |
Why?
|
| Rats, Mutant Strains | 1 | 2017 | 14 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2018 | 46 | 0.030 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2017 | 21 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 142 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 821 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 633 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 570 | 0.030 |
Why?
|
| Chromosomes, Insect | 1 | 2017 | 5 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 394 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3359 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2018 | 97 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 429 | 0.030 |
Why?
|
| Iceland | 1 | 2016 | 12 | 0.030 |
Why?
|
| Ketoglutaric Acids | 1 | 2016 | 26 | 0.030 |
Why?
|
| Genitalia | 1 | 2016 | 39 | 0.030 |
Why?
|
| Asthma | 1 | 2025 | 922 | 0.030 |
Why?
|
| Speech Disorders | 1 | 2016 | 47 | 0.030 |
Why?
|
| Polyubiquitin | 1 | 2016 | 8 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2016 | 116 | 0.030 |
Why?
|
| Regeneration | 1 | 2019 | 230 | 0.030 |
Why?
|
| alpha-Synuclein | 1 | 2017 | 143 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 981 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 333 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 1722 | 0.030 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2016 | 28 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2016 | 112 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 179 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 172 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 187 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2114 | 0.030 |
Why?
|
| Citrate (si)-Synthase | 1 | 2015 | 17 | 0.030 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2015 | 11 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 587 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 173 | 0.030 |
Why?
|
| Membrane Fusion | 1 | 2015 | 37 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2015 | 4 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2016 | 148 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 33 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 200 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2016 | 199 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2015 | 63 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 407 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 106 | 0.030 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2014 | 6 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2014 | 89 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 1287 | 0.030 |
Why?
|
| Mutagens | 1 | 2014 | 46 | 0.030 |
Why?
|
| Seizures | 1 | 2020 | 890 | 0.030 |
Why?
|
| Genes, Essential | 1 | 2014 | 39 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2065 | 0.030 |
Why?
|
| DNA | 1 | 2019 | 1399 | 0.030 |
Why?
|
| Protein Prenylation | 1 | 2014 | 8 | 0.030 |
Why?
|
| Placenta Previa | 1 | 2014 | 66 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6459 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2014 | 156 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 71 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 243 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2017 | 385 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 2730 | 0.030 |
Why?
|
| Insect Hormones | 1 | 2013 | 5 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 155 | 0.020 |
Why?
|
| Leigh Disease | 1 | 2013 | 24 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 2026 | 0.020 |
Why?
|
| Longevity | 1 | 2014 | 178 | 0.020 |
Why?
|
| Superior Colliculi | 1 | 2012 | 13 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 4066 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2012 | 56 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2012 | 249 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2014 | 346 | 0.020 |
Why?
|
| Cholesterol | 1 | 2014 | 539 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5196 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 378 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1801 | 0.020 |
Why?
|
| United States | 2 | 2018 | 12072 | 0.020 |
Why?
|
| Homeostasis | 1 | 2015 | 712 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 791 | 0.020 |
Why?
|
| Dextrans | 1 | 2010 | 42 | 0.020 |
Why?
|
| Biotin | 1 | 2010 | 39 | 0.020 |
Why?
|
| Calcium | 1 | 2015 | 1010 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2013 | 767 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2010 | 57 | 0.020 |
Why?
|
| Brain Stem | 1 | 2010 | 108 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 2200 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 3385 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 246 | 0.020 |
Why?
|
| Tooth | 1 | 2007 | 16 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 88 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 3061 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 107 | 0.020 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2006 | 9 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2006 | 48 | 0.020 |
Why?
|
| Antigens | 1 | 2006 | 105 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2006 | 77 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 1889 | 0.020 |
Why?
|
| Retroviridae | 1 | 2006 | 182 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2006 | 96 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 358 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2833 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 1205 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 555 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2006 | 713 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 12936 | 0.010 |
Why?
|